Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 567 entries
Sorted by: Best Match Show Resources per page
Charms of a silver watch.

Current oncology (Toronto, Ont.)

Bawany SA.
PMID: 26089733
Curr Oncol. 2015 Jun;22(3):e228-9. doi: 10.3747/co.22.2369.

No abstract available.

Cite
Bawany SA. Charms of a silver watch. Curr Oncol. 2015;22(3):e228-9doi: 10.3747/co.22.2369.
Bawany, S. A. (2015). Charms of a silver watch. Current oncology (Toronto, Ont.), 22(3), e228-9. https://doi.org/10.3747/co.22.2369
Bawany, S A. "Charms of a silver watch." Current oncology (Toronto, Ont.) vol. 22,3 (2015): e228-9. doi: https://doi.org/10.3747/co.22.2369
Bawany SA. Charms of a silver watch. Curr Oncol. 2015 Jun;22(3):e228-9. doi: 10.3747/co.22.2369. PMID: 26089733; PMCID: PMC4462547.
Copy Download .nbib Format: NLM
[Obesity: concept, classification and diagnosis].

Anales del sistema sanitario de Navarra

Barbany M, Foz M.
PMID: 12861266
An Sist Sanit Navar. 2002;25:7-16. doi: 10.23938/ASSN.0810.

Obesity is a chronic disease that is characterised by an increase of fat mass and as a result by an increase in weight. There is therefore an increase in the energy reserves of the organism in the form of...

Cite
Barbany M, Foz M. Obesidad: concepto, clasificación y diagnóstico. [Obesity: concept, classification and diagnosis]. An Sist Sanit Navar. 2002;25:7-16doi: 10.23938/ASSN.0810.
Barbany, M., & Foz, M. (2002). Obesidad: concepto, clasificación y diagnóstico. [Obesity: concept, classification and diagnosis]. Anales del sistema sanitario de Navarra, 257-16. https://doi.org/10.23938/ASSN.0810
Barbany, M, and Foz, M. "Obesidad: concepto, clasificación y diagnóstico." [Obesity: concept, classification and diagnosis]. Anales del sistema sanitario de Navarra vol. 25 (2002): 7-16. doi: https://doi.org/10.23938/ASSN.0810
Barbany M, Foz M. Obesidad: concepto, clasificación y diagnóstico. [Obesity: concept, classification and diagnosis]. An Sist Sanit Navar. 2002;25:7-16. doi: 10.23938/ASSN.0810. Spanish. PMID: 12861266.
Copy Download .nbib Format: NLM
Stability-indicating method for the determination of clorazepate dipotassium-II. Via N-desmethyldiazepam and determination of its degradation products.

Talanta

El-Bardicy MG, Bebawy LI, Amer MM.
PMID: 18965536
Talanta. 1992 Oct;39(10):1323-7. doi: 10.1016/0039-9140(92)80245-9.

A spectrophotometric method for the determination of the intact clorazepate dipotassium in the presence of its degradation products is developed. It depends upon preliminary hydrolysis of clorazepate dipotassium-thus liberating its equivalent of N-desmethyldiazepam which is extracted, with benzene-methylene chloride...

Cite
El-Bardicy MG, Bebawy LI, Amer MM. Stability-indicating method for the determination of clorazepate dipotassium-II. Via N-desmethyldiazepam and determination of its degradation products. Talanta. 1992;39(10):1323-7doi: 10.1016/0039-9140(92)80245-9.
El-Bardicy, M. G., Bebawy, L. I., & Amer, M. M. (1992). Stability-indicating method for the determination of clorazepate dipotassium-II. Via N-desmethyldiazepam and determination of its degradation products. Talanta, 39(10), 1323-7. https://doi.org/10.1016/0039-9140(92)80245-9
El-Bardicy, M G, et al. "Stability-indicating method for the determination of clorazepate dipotassium-II. Via N-desmethyldiazepam and determination of its degradation products." Talanta vol. 39,10 (1992): 1323-7. doi: https://doi.org/10.1016/0039-9140(92)80245-9
El-Bardicy MG, Bebawy LI, Amer MM. Stability-indicating method for the determination of clorazepate dipotassium-II. Via N-desmethyldiazepam and determination of its degradation products. Talanta. 1992 Oct;39(10):1323-7. doi: 10.1016/0039-9140(92)80245-9. PMID: 18965536.
Copy Download .nbib Format: NLM
Stability-indicating method for the determination of clorazepate dipotassium-I. Via its final degradation products.

Talanta

El-Bardicy MG, Bebawy LI, Amer MM.
PMID: 18965571
Talanta. 1992 Dec;39(12):1569-73. doi: 10.1016/0039-9140(92)80184-f.

A sensitive spectrophotometric procedure is described for the determination of 1,4-benzodiazepine (clorazepate dipotassium) in the presence of its degradation products. The procedure is based on acid hydrolysis of clorazepate dipotassium to yield its final degradation products viz., 2-amino-5-chlorobenzophenone and...

Cite
El-Bardicy MG, Bebawy LI, Amer MM. Stability-indicating method for the determination of clorazepate dipotassium-I. Via its final degradation products. Talanta. 1992;39(12):1569-73doi: 10.1016/0039-9140(92)80184-f.
El-Bardicy, M. G., Bebawy, L. I., & Amer, M. M. (1992). Stability-indicating method for the determination of clorazepate dipotassium-I. Via its final degradation products. Talanta, 39(12), 1569-73. https://doi.org/10.1016/0039-9140(92)80184-f
El-Bardicy, M G, et al. "Stability-indicating method for the determination of clorazepate dipotassium-I. Via its final degradation products." Talanta vol. 39,12 (1992): 1569-73. doi: https://doi.org/10.1016/0039-9140(92)80184-f
El-Bardicy MG, Bebawy LI, Amer MM. Stability-indicating method for the determination of clorazepate dipotassium-I. Via its final degradation products. Talanta. 1992 Dec;39(12):1569-73. doi: 10.1016/0039-9140(92)80184-f. PMID: 18965571.
Copy Download .nbib Format: NLM
Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.

Cancer research

Bacolod MD, Schemmann GS, Giardina SF, Paty P, Notterman DA, Barany F.
PMID: 19155292
Cancer Res. 2009 Feb 01;69(3):723-7. doi: 10.1158/0008-5472.CAN-08-3543. Epub 2009 Jan 20.

High-density single nucleotide polymorphism (SNP) mapping arrays have identified chromosomal features whose importance to cancer predisposition and progression is not yet clearly defined. Of interest is that the genomes of normal somatic cells (reflecting the combined parental germ-line contributions)...

Cite
Bacolod MD, Schemmann GS, Giardina SF, et al. Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies. Cancer Res. 2009;69(3):723-7doi: 10.1158/0008-5472.CAN-08-3543.
Bacolod, M. D., Schemmann, G. S., Giardina, S. F., Paty, P., Notterman, D. A., & Barany, F. (2009). Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies. Cancer research, 69(3), 723-7. https://doi.org/10.1158/0008-5472.CAN-08-3543
Bacolod, Manny D, et al. "Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies." Cancer research vol. 69,3 (2009): 723-7. doi: https://doi.org/10.1158/0008-5472.CAN-08-3543
Bacolod MD, Schemmann GS, Giardina SF, Paty P, Notterman DA, Barany F. Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies. Cancer Res. 2009 Feb 01;69(3):723-7. doi: 10.1158/0008-5472.CAN-08-3543. Epub 2009 Jan 20. PMID: 19155292; PMCID: PMC4378658.
Copy Download .nbib Format: NLM
Selective extraction and transport of copper(II) with new alkylated pyridinecarboxylic acid derivatives.

Talanta

Tasaki T, Oshima T, Baba Y.
PMID: 19073044
Talanta. 2007 Sep 15;73(2):387-93. doi: 10.1016/j.talanta.2007.04.001. Epub 2007 Apr 07.

Two kinds of N-(6-alkylamido)-2-pyridine carboxylic acid with a pyridine moiety and a carboxylic acid as chelating ligands were newly synthesized for the selective extraction and the transport of copper(II) from aqueous solution. Liquid-liquid extraction was carried out to examine...

Cite
Tasaki T, Oshima T, Baba Y. Selective extraction and transport of copper(II) with new alkylated pyridinecarboxylic acid derivatives. Talanta. 2007;73(2):387-93doi: 10.1016/j.talanta.2007.04.001.
Tasaki, T., Oshima, T., & Baba, Y. (2007). Selective extraction and transport of copper(II) with new alkylated pyridinecarboxylic acid derivatives. Talanta, 73(2), 387-93. https://doi.org/10.1016/j.talanta.2007.04.001
Tasaki, Tsutomu, et al. "Selective extraction and transport of copper(II) with new alkylated pyridinecarboxylic acid derivatives." Talanta vol. 73,2 (2007): 387-93. doi: https://doi.org/10.1016/j.talanta.2007.04.001
Tasaki T, Oshima T, Baba Y. Selective extraction and transport of copper(II) with new alkylated pyridinecarboxylic acid derivatives. Talanta. 2007 Sep 15;73(2):387-93. doi: 10.1016/j.talanta.2007.04.001. Epub 2007 Apr 07. PMID: 19073044.
Copy Download .nbib Format: NLM
Metal-free Brønsted acid catalyzed formal [3 + 3] annulation. straightforward synthesis of dihydro-2H-chromenones, pyranones, and tetrahydroquinolinones.

The Journal of organic chemistry

Moreau J, Hubert C, Batany J, Toupet L, Roisnel T, Hurvois JP, Renaud JL.
PMID: 19950880
J Org Chem. 2009 Dec 04;74(23):8963-73. doi: 10.1021/jo901238y.

Brønsted acids catalyze the addition of enolizable beta-diketones, beta-ketoesters, and vinylogous amides to alpha,beta-unsaturated aldehydes to lead to substituted chromenones, pyranones, and tetrahydroquinolinones in good yields under mild reaction conditions via a formal [3 + 3] cycloaddition.

Cite
Moreau J, Hubert C, Batany J, et al. Metal-free Brønsted acid catalyzed formal [3 + 3] annulation. straightforward synthesis of dihydro-2H-chromenones, pyranones, and tetrahydroquinolinones. J Org Chem. 2009;74(23):8963-73doi: 10.1021/jo901238y.
Moreau, J., Hubert, C., Batany, J., Toupet, L., Roisnel, T., Hurvois, J. P., & Renaud, J. L. (2009). Metal-free Brønsted acid catalyzed formal [3 + 3] annulation. straightforward synthesis of dihydro-2H-chromenones, pyranones, and tetrahydroquinolinones. The Journal of organic chemistry, 74(23), 8963-73. https://doi.org/10.1021/jo901238y
Moreau, Julie, et al. "Metal-free Brønsted acid catalyzed formal [3 + 3] annulation. straightforward synthesis of dihydro-2H-chromenones, pyranones, and tetrahydroquinolinones." The Journal of organic chemistry vol. 74,23 (2009): 8963-73. doi: https://doi.org/10.1021/jo901238y
Moreau J, Hubert C, Batany J, Toupet L, Roisnel T, Hurvois JP, Renaud JL. Metal-free Brønsted acid catalyzed formal [3 + 3] annulation. straightforward synthesis of dihydro-2H-chromenones, pyranones, and tetrahydroquinolinones. J Org Chem. 2009 Dec 04;74(23):8963-73. doi: 10.1021/jo901238y. PMID: 19950880.
Copy Download .nbib Format: NLM
Epstein-Barr virus myelitis and Castleman's disease in a patient with acquired immune deficiency syndrome: a case report.

Journal of medical case reports

Albany C, Psevdos G, Balderacchi J, Sharp VL.
PMID: 21615962
J Med Case Rep. 2011 May 27;5:209. doi: 10.1186/1752-1947-5-209.

INTRODUCTION: Few cases of Epstein-Barr virus myelitis have been described in the literature. Multi-centric Castleman's disease is a lymphoproliferative disorder that is well known for its associations with the human immunodeficiency virus, human herpes virus 8, and Kaposi's sarcoma....

Cite
Albany C, Psevdos G, Balderacchi J, et al. Epstein-Barr virus myelitis and Castleman's disease in a patient with acquired immune deficiency syndrome: a case report. J Med Case Rep. 2011;5:209doi: 10.1186/1752-1947-5-209.
Albany, C., Psevdos, G., Balderacchi, J., & Sharp, V. L. (2011). Epstein-Barr virus myelitis and Castleman's disease in a patient with acquired immune deficiency syndrome: a case report. Journal of medical case reports, 5209. https://doi.org/10.1186/1752-1947-5-209
Albany, Costantine, et al. "Epstein-Barr virus myelitis and Castleman's disease in a patient with acquired immune deficiency syndrome: a case report." Journal of medical case reports vol. 5 (2011): 209. doi: https://doi.org/10.1186/1752-1947-5-209
Albany C, Psevdos G, Balderacchi J, Sharp VL. Epstein-Barr virus myelitis and Castleman's disease in a patient with acquired immune deficiency syndrome: a case report. J Med Case Rep. 2011 May 27;5:209. doi: 10.1186/1752-1947-5-209. PMID: 21615962; PMCID: PMC3128854.
Copy Download .nbib Format: NLM
Association between changes in body composition and the increasing prevalence of fatty liver in Japanese men.

Hepatology research : the official journal of the Japan Society of Hepatology

Imamura Y, Uto H, Oketani M, Hiramine Y, Hosoyamada K, Sho Y, Hiwaki T, Baba Y, Tahara K, Kubozono O, Kusano K, Tsubouchi H.
PMID: 18564141
Hepatol Res. 2008;38(11):1083-6. doi: 10.1111/j.1872-034X.2008.00383.x. Epub 2008 Jun 17.

AIM: Prevalence of fatty liver is increasing. In this study, to elucidate the factor that contributes most to recent increases in prevalence of fatty liver, we determined the independent predictors for the onset of fatty liver and compared these...

Cite
Imamura Y, Uto H, Oketani M, et al. Association between changes in body composition and the increasing prevalence of fatty liver in Japanese men. Hepatol Res. 2008;38(11):1083-6doi: 10.1111/j.1872-034X.2008.00383.x.
Imamura, Y., Uto, H., Oketani, M., Hiramine, Y., Hosoyamada, K., Sho, Y., Hiwaki, T., Baba, Y., Tahara, K., Kubozono, O., Kusano, K., & Tsubouchi, H. (2008). Association between changes in body composition and the increasing prevalence of fatty liver in Japanese men. Hepatology research : the official journal of the Japan Society of Hepatology, 38(11), 1083-6. https://doi.org/10.1111/j.1872-034X.2008.00383.x
Imamura, Yasushi, et al. "Association between changes in body composition and the increasing prevalence of fatty liver in Japanese men." Hepatology research : the official journal of the Japan Society of Hepatology vol. 38,11 (2008): 1083-6. doi: https://doi.org/10.1111/j.1872-034X.2008.00383.x
Imamura Y, Uto H, Oketani M, Hiramine Y, Hosoyamada K, Sho Y, Hiwaki T, Baba Y, Tahara K, Kubozono O, Kusano K, Tsubouchi H. Association between changes in body composition and the increasing prevalence of fatty liver in Japanese men. Hepatol Res. 2008;38(11):1083-6. doi: 10.1111/j.1872-034X.2008.00383.x. Epub 2008 Jun 17. PMID: 18564141.
Copy Download .nbib Format: NLM
Whipple's endocarditis: An enigmatic cause of culture-negative bacterial endocarditis.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Weisman A, Rebick G, Morris A, Butany J, Liles WC.
PMID: 24421813
Can J Infect Dis Med Microbiol. 2013;24(2):e29-30. doi: 10.1155/2013/138746.

No abstract available.

Cite
Weisman A, Rebick G, Morris A, et al. Whipple's endocarditis: An enigmatic cause of culture-negative bacterial endocarditis. Can J Infect Dis Med Microbiol. 2013;24(2):e29-30doi: 10.1155/2013/138746.
Weisman, A., Rebick, G., Morris, A., Butany, J., & Liles, W. C. (2013). Whipple's endocarditis: An enigmatic cause of culture-negative bacterial endocarditis. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 24(2), e29-30. https://doi.org/10.1155/2013/138746
Weisman, Alanna, et al. "Whipple's endocarditis: An enigmatic cause of culture-negative bacterial endocarditis." The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale vol. 24,2 (2013): e29-30. doi: https://doi.org/10.1155/2013/138746
Weisman A, Rebick G, Morris A, Butany J, Liles WC. Whipple's endocarditis: An enigmatic cause of culture-negative bacterial endocarditis. Can J Infect Dis Med Microbiol. 2013;24(2):e29-30. doi: 10.1155/2013/138746. PMID: 24421813; PMCID: PMC3720009.
Copy Download .nbib Format: NLM
Synchronous EUS-guided choledochoduodenostomy with metallic biliary and duodenal stents placement in a patient with malignant papillary tumor.

Journal of interventional gastroenterology

Thotakura RV, Thotakura S, Sofi A, Bawany MZ, Nawras A.
PMID: 23687594
J Interv Gastroenterol. 2012 Apr;2(2):88-90. doi: 10.4161/jig.22206. Epub 2012 Apr 01.

No abstract available.

Cite
Thotakura RV, Thotakura S, Sofi A, et al. Synchronous EUS-guided choledochoduodenostomy with metallic biliary and duodenal stents placement in a patient with malignant papillary tumor. J Interv Gastroenterol. 2012;2(2):88-90doi: 10.4161/jig.22206.
Thotakura, R. V., Thotakura, S., Sofi, A., Bawany, M. Z., & Nawras, A. (2012). Synchronous EUS-guided choledochoduodenostomy with metallic biliary and duodenal stents placement in a patient with malignant papillary tumor. Journal of interventional gastroenterology, 2(2), 88-90. https://doi.org/10.4161/jig.22206
Thotakura, Raja V, et al. "Synchronous EUS-guided choledochoduodenostomy with metallic biliary and duodenal stents placement in a patient with malignant papillary tumor." Journal of interventional gastroenterology vol. 2,2 (2012): 88-90. doi: https://doi.org/10.4161/jig.22206
Thotakura RV, Thotakura S, Sofi A, Bawany MZ, Nawras A. Synchronous EUS-guided choledochoduodenostomy with metallic biliary and duodenal stents placement in a patient with malignant papillary tumor. J Interv Gastroenterol. 2012 Apr;2(2):88-90. doi: 10.4161/jig.22206. Epub 2012 Apr 01. PMID: 23687594; PMCID: PMC3655349.
Copy Download .nbib Format: NLM
Epigenetics in prostate cancer.

Prostate cancer

Albany C, Alva AS, Aparicio AM, Singal R, Yellapragada S, Sonpavde G, Hahn NM.
PMID: 22191037
Prostate Cancer. 2011;2011:580318. doi: 10.1155/2011/580318. Epub 2011 Nov 30.

Prostate cancer (PC) is the most commonly diagnosed nonskin malignancy and the second most common cause of cancer death among men in the United States. Epigenetics is the study of heritable changes in gene expression caused by mechanisms other...

Cite
Albany C, Alva AS, Aparicio AM, et al. Epigenetics in prostate cancer. Prostate Cancer. 2011;2011:580318doi: 10.1155/2011/580318.
Albany, C., Alva, A. S., Aparicio, A. M., Singal, R., Yellapragada, S., Sonpavde, G., & Hahn, N. M. (2011). Epigenetics in prostate cancer. Prostate cancer, 2011580318. https://doi.org/10.1155/2011/580318
Albany, Costantine, et al. "Epigenetics in prostate cancer." Prostate cancer vol. 2011 (2011): 580318. doi: https://doi.org/10.1155/2011/580318
Albany C, Alva AS, Aparicio AM, Singal R, Yellapragada S, Sonpavde G, Hahn NM. Epigenetics in prostate cancer. Prostate Cancer. 2011;2011:580318. doi: 10.1155/2011/580318. Epub 2011 Nov 30. PMID: 22191037; PMCID: PMC3236424.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 567 entries